Chronic Care Management: Focus on Anticoagulation

Friday, February 7, 2020 - 1:15-3:15 pm
 
0107-9999-20-029-L01-P
0.2 CEU/2.0 hr
 
This course will provide a clinically-intensive review of anticoagulation with an emphasis on the role of direct acting anticoagulants (DOACs) in patients with oncology or cardiovascular disease as well as when to consider extended therapy. Hear tips on how to establish a DOAC monitoring service at your practice setting. Come prepared to be challenged by discussion on complex scenarios that will provide the tools you need to promote optimal patient care.
 
Learning Objectives
Upon successful completion of this application-based CPE activity, participants should be able to:
 
1. Identify candidates for extended anticoagulation therapy following venous thromboembolism (VTE) and select corresponding direct acting anticoagulant (DOAC) regimen.
2. Discuss the role of DOACs in prevention and treatment of VTE in patients with cancer.
3. Evaluate clinical trials assessing the role of direct oral anticoagulants in patients with stable cardiovascular disease.
4. Identify the role of direct oral anticoagulants in patients with atrial fibrillation who have undergone a percutaneous coronary intervention.

Andrew Miesner
Andrew Miesner, PharmD, BCPS

Associate Professor of Pharmacy Practice
Drake University College of Pharmacy & Health Sciences
Des Moines, IA


Tadd Hellwig

Tadd Hellwig, PharmD, BCPS, FASHP

Professor/Clinical Pharmacist
South Dakota State College of Pharmacy and Allied
Health Professions/Sanford USD Medical Center
Sioux Falls, SD

Sara Wiedenfeld

Sara Wiedenfeld, PharmD, BCPS

Clinical Assistant Professor
University of Iowa College of Pharmacy
Sioux City, IA